# Estrella Immunopharma, Inc.: Form 8-K, filed Dec 16, 2024

- Company: [Estrella Immunopharma, Inc.](/companies/esla.md) (CIK 1844417)
- Form: 8-K
- Filed: 2024-12-16
- Accepted by EDGAR: Dec 16, 2024, 16:00 ET
- Period: 2024-12-16
- Accession: 0001213900-24-109285
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1844417/000121390024109285/ea0224902-8k_estella.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1844417/000121390024109285/

## Items reported

- Item 8.01: Other events

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1844417/000121390024109285/ea0224902-8k_estella.htm

Filed Dec 16, 2024.
Source: SEC EDGAR, the filing index for accession 0001213900-24-109285. Last ingested by Listed: Nov 4, 2026, 07:37 ET. No prices; not investment advice.